Posting this under the heading it deserves: Second pass at: When a network meta-analysis is defensible and when it is not Everything below is what sits behind that.
Comparing STEP 8 (JAMA, 2022) with LEADER (N Engl J Med, 2016) and finding the comparison harder than it looks.
Different populations, different durations, different endpoints defined slightly differently, and in one case a different estimand. People compare the headline percentages anyway, including me until recently.
Is there a defensible way to put these side by side, or is the honest answer that there is not and we should stop?